关注
George R Thompson
George R Thompson
Professor of Medicine, Division of Infectious Diseases, University of California - Davis
在 ucdavis.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
53122020
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical infectious diseases 63 (4), e1-e60, 2016
25032016
Baricitinib plus remdesivir for hospitalized adults with Covid-19
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
15602021
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
15012020
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled …
JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ...
The Lancet 387 (10020), 760-769, 2016
7802016
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ...
The Lancet infectious diseases 16 (7), 828-837, 2016
6032016
Coccidioidomycosis: epidemiology
J Brown, K Benedict, BJ Park, GR Thompson III
Clinical epidemiology, 185-197, 2013
2902013
Oropharyngeal candidiasis in the era of antiretroviral therapy
GR Thompson III, PK Patel, WR Kirkpatrick, SD Westbrook, D Berg, ...
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2010
2202010
Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation
G Jiang, EA Mendes, P Kaiser, DP Wong, Y Tang, I Cai, A Fenton, ...
PLoS pathogens 11 (7), e1005066, 2015
1842015
Overview of antifungal agents
GR Thompson, J Cadena, TF Patterson
Clinics in chest medicine 30 (2), 203-215, 2009
1822009
Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
GR Thompson III, NP Wiederhold, AC Vallor, NC Villareal, JS Lewis, ...
Antimicrobial agents and chemotherapy 52 (10), 3783-3785, 2008
1812008
Isavuconazole treatment of cryptococcosis and dimorphic mycoses
GR Thompson, A Rendon, R Ribeiro dos Santos, F Queiroz-Telles, ...
Reviews of Infectious Diseases 63 (3), 356-362, 2016
1792016
Valley Fever: Finding New Places for an Old Disease: Coccidioides immitis Found in Washington State Soil Associated With Recent Human Infection
AP Litvintseva, N Marsden-Haug, S Hurst, H Hill, L Gade, EM Driebe, ...
Clinical Infectious Diseases 60 (1), e1-e3, 2015
1722015
Coccidioidomycosis
NW Stockamp, GR Thompson
Infectious Disease Clinics 30 (1), 229-246, 2016
1612016
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole
GR Thompson, NP Wiederhold
Mycopathologia 170, 291-313, 2010
1542010
Aspiring antifungals: review of current antifungal pipeline developments
TJ Gintjee, MA Donnelley, GR Thompson III
Journal of Fungi 6 (1), 28, 2020
1512020
Fungal disease of the nose and paranasal sinuses
GR Thompson III, TF Patterson
Journal of allergy and clinical immunology 129 (2), 321-326, 2012
1472012
Invasive aspergillosis: current strategies for diagnosis and management
J Cadena, GR Thompson, TF Patterson
Infectious Disease Clinics 30 (1), 125-142, 2016
1462016
Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
GR Thompson III, NP Wiederhold, AW Fothergill, AC Vallor, BL Wickes, ...
Antimicrobial Agents and Chemotherapy 53 (1), 309-311, 2009
1422009
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
BJ Kullberg, C Viscoli, PG Pappas, J Vazquez, L Ostrosky-Zeichner, ...
Clinical Infectious Diseases 68 (12), 1981-1989, 2019
1402019
系统目前无法执行此操作,请稍后再试。
文章 1–20